Skip to content

Ukraine strikes deal with Clinton Foundation for cheaper HIV drugs

UK gives $5.3 million to Global Fund in bid to trigger US cash release by month's close

India: Global Fund boss optimistic on HIV progress; controversy continues on size of epidemic

Spontaneous hepatitis C virus clearance occurs in up to 42% recently infected, HIV-negative IDUs

Does long-term HAART lead to a resurgence in immune activation and fall in CD4 count?

Microbicide Development Programme drops Emmelle for PRO 2000

Rare sexually transmitted infection seen in a cluster of HIV-positive men

Abacavir/3TC once daily pill gets scientific approval as Kivexa in Europe

Higher immune system activation prior to seroconversion leads to faster CD4 T-cell loss